Literature DB >> 8867254

Experimental pain stimulates respiration and attenuates morphine-induced respiratory depression: a controlled study in human volunteers.

Molke F Borgbjerg1, Kurt Nielsen, Jan Franks.   

Abstract

Although evidence is lacking, clinical experience suggests that pain stimulation acts as a respiratory stimulant and antagonises opioid-induced respiratory depression. The present study examined the effects of experimental pain stimulation on the ventilatory response to CO2 and morphine-induced respiratory depression. Pain was induced by a modification of the Tourniquet Pain Technique and changes in ventilatory parameters were registered through monitoring of the CO2 response of tidal volume, minute ventilation, respiratory rate and mouth occlusion pressure. The ventilatory parameters were obtained before and during pain stimulation and repeated after the administration of morphine and finally after naloxone. In the present investigation experimental pain-stimulated respiration and attenuated morphine-induced respiratory depression. Only changes in the intercept values of the CO2 response were observed. The slopes of the CO2-response curves were not affected. These observations suggested that both pain stimulation and morphine administration altered the threshold of the respiratory centre to CO2 stimulation. Naloxone administration was the only intervention altering the sensitivity of the respiratory centre to CO2. These results suggest that pain stimulates respiration and attenuates morphine-induced respiratory depression.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8867254     DOI: 10.1016/0304-3959(95)00088-7

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  27 in total

Review 1.  Contribution to variability in response to opioids.

Authors:  Geoffrey W Hanks; Colette Reid
Journal:  Support Care Cancer       Date:  2004-12-10       Impact factor: 3.603

Review 2.  Prescription Opioid Fatalities: Examining Why the Healer Could be the Culprit.

Authors:  Adeleke D Adewumi; Christine E Staatz; Samantha A Hollingworth; Jason P Connor; Rosa Alati
Journal:  Drug Saf       Date:  2018-11       Impact factor: 5.606

3.  Fatal PCA Adverse Events Continue To Happen: Better Patient Monitoring Is Essential to Prevent Harm.

Authors:  Matthew Grissinger
Journal:  P T       Date:  2016-12

Review 4.  Mechanism of augmented exercise hyperpnea in chronic heart failure and dead space loading.

Authors:  Chi-Sang Poon; Chung Tin
Journal:  Respir Physiol Neurobiol       Date:  2012-12-27       Impact factor: 1.931

5.  Effects of cold pressor pain on the abuse liability of intranasal oxycodone in male and female prescription opioid abusers.

Authors:  Michelle R Lofwall; Paul A Nuzzo; Sharon L Walsh
Journal:  Drug Alcohol Depend       Date:  2011-12-30       Impact factor: 4.492

6.  Prescribed Dose of Opioids and Overdose: A Systematic Review and Meta-Analysis of Unintentional Prescription Opioid Overdose.

Authors:  Adeleke D Adewumi; Samantha A Hollingworth; Joemer C Maravilla; Jason P Connor; Rosa Alati
Journal:  CNS Drugs       Date:  2018-02       Impact factor: 5.749

7.  Effect of P-glycoprotein modulation on the clinical pharmacokinetics and adverse effects of morphine.

Authors:  J Drewe; H A Ball; C Beglinger; B Peng; A Kemmler; H Schächinger; W E Haefeli
Journal:  Br J Clin Pharmacol       Date:  2000-09       Impact factor: 4.335

Review 8.  Chronic non-malignant musculoskeletal pain in older adults: clinical issues and opioid intervention.

Authors:  V K Podichetty; D J Mazanec; R S Biscup
Journal:  Postgrad Med J       Date:  2003-11       Impact factor: 2.401

9.  Oral morphine and respiratory function amongst hospice inpatients with advanced cancer.

Authors:  T D Walsh; N I Rivera; R Kaiko
Journal:  Support Care Cancer       Date:  2003-10-24       Impact factor: 3.603

10.  Acute effects of opioids on memory functions of healthy men and women.

Authors:  James Friswell; Caroline Phillips; James Holding; Celia J A Morgan; Brigitta Brandner; H Valerie Curran
Journal:  Psychopharmacology (Berl)       Date:  2008-04-01       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.